title: Is it time for some new approaches for treating advanced ovarian cancer?
authors.forename: William P
authors.initials: WP
authors.lastname: McGuire
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy; D016190:Carboplatin / Q000008:administration & dosage; D017326:Clinical Trials, Phase III as Topic; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D019772:Topotecan / Q000008:administration & dosage; D017211:Treatment Failure
chemical_list: D019772:Topotecan; D016190:Carboplatin; D017239:Paclitaxel